JOSÉ MARÍA
GUINEA DE CASTRO
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPharmacoeconomics and Outcomes Research Iberia-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with cd-33 positive acute myeloid leukaemia in spain
ClinicoEconomics and Outcomes Research, Vol. 13, pp. 263-277